Black Diamond Therapeutics Inc

NASDAQ:BDTX  
3.85
-0.12 (-3.02%)
Other Pre-Announcement

Black Diamond Therapeutics Announces Strategic Priorities And Expected Milestones For 2022

Published: 01/10/2022 12:24 GMT
Black Diamond Therapeutics Inc (BDTX) - Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022.
Black Diamond Therapeutics Inc - Anticipates Initiation of Ind-enabling Studies for Its Cns-penetrant Class I,ii,iii Braf Program in 2022.
Black Diamond Therapeutics Inc - Cash Runway Extended to 2024.